Meeting
2014 Genitourinary Cancers Symposium
Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets.
Authors
Philip H. Kim
Memorial Sloan-Kettering Cancer Center, New York, NY
Philip H. Kim , John P. Sfakianos , Sasinya N. Scott , Gopa Iyer , Eugene K. Cha , Hikmat Al-Ahmadie , Arony J. Sun , Ilana Rebecca Garcia-Grossman , Richard Martin Bambury , Guido Dalbagni , Jonathan E. Rosenberg , Dean F. Bajorin , Michael F. Berger , David B. Solit , Bernard H. Bochner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 32, 2014 (suppl 4; abstr 308)
DOI
10.1200/jco.2014.32.4_suppl.308
Abstract #
308
Poster Bd #
G14
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer (BC) analysis.
First Author: Jonathan E. Rosenberg
Poster
2017 Genitourinary Cancers Symposium
Dissecting the genomic landscape of metastatic bladder cancer using circulating tumor DNA.
First Author: Werner J. Struss
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes
Poster
2014 ASCO Annual Meeting
Comprehensive molecular profiling of urothelial bladder cancer at the DNA, RNA, and protein levels: A TCGA project.
First Author: John N. Weinstein